A detailed history of Securian Asset Management, Inc transactions in Repligen Corp stock. As of the latest transaction made, Securian Asset Management, Inc holds 4,044 shares of RGEN stock, worth $584,196. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,044
Previous 4,144 2.41%
Holding current value
$584,196
Previous $522,000 15.13%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.79 - $167.35 $11,979 - $16,735
-100 Reduced 2.41%
4,044 $601,000
Q2 2024

Jul 15, 2024

SELL
$120.0 - $182.95 $17,640 - $26,893
-147 Reduced 3.43%
4,144 $522,000
Q1 2024

Apr 26, 2024

SELL
$170.78 - $208.42 $17,078 - $20,842
-100 Reduced 2.28%
4,291 $789,000
Q3 2023

Oct 30, 2023

SELL
$138.78 - $176.51 $29,005 - $36,890
-209 Reduced 4.54%
4,391 $698,000
Q2 2023

Aug 07, 2023

SELL
$138.42 - $180.31 $13,841 - $18,031
-100 Reduced 2.13%
4,600 $650,000
Q1 2023

Apr 27, 2023

SELL
$154.26 - $198.1 $15,426 - $19,810
-100 Reduced 2.08%
4,700 $791,000
Q4 2022

Feb 02, 2023

BUY
$162.42 - $220.56 $16,241 - $22,056
100 Added 2.13%
4,800 $812,000
Q2 2022

Aug 04, 2022

BUY
$140.68 - $188.02 $16,178 - $21,622
115 Added 2.51%
4,700 $763,000
Q3 2021

Nov 08, 2021

SELL
$194.77 - $324.21 $21,035 - $35,014
-108 Reduced 2.3%
4,585 $1.33 Million
Q2 2021

Aug 10, 2021

SELL
$165.87 - $220.95 $19,572 - $26,072
-118 Reduced 2.45%
4,693 $937,000
Q1 2021

May 10, 2021

BUY
$180.37 - $226.26 $18,037 - $22,626
100 Added 2.12%
4,811 $935,000
Q2 2020

Aug 06, 2020

SELL
$94.33 - $140.48 $9,433 - $14,047
-100 Reduced 2.08%
4,711 $582,000
Q4 2019

Feb 04, 2020

SELL
$73.84 - $93.08 $29,092 - $36,673
-394 Reduced 7.57%
4,811 $445,000
Q3 2019

Nov 12, 2019

BUY
$76.65 - $95.51 $398,963 - $497,129
5,205 New
5,205 $399,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Securian Asset Management, Inc Portfolio

Follow Securian Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.